# To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females

> **NCT00651534** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 32 (—)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Ronacaleret

## Key facts

- **NCT ID:** NCT00651534
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 32 (—)
- **Last updated:** 2016-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651534, "To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00651534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*